JPS5914788A - Stabilization of l-alpha-glycerol-3-phosphate oxidase - Google Patents
Stabilization of l-alpha-glycerol-3-phosphate oxidaseInfo
- Publication number
- JPS5914788A JPS5914788A JP12364782A JP12364782A JPS5914788A JP S5914788 A JPS5914788 A JP S5914788A JP 12364782 A JP12364782 A JP 12364782A JP 12364782 A JP12364782 A JP 12364782A JP S5914788 A JPS5914788 A JP S5914788A
- Authority
- JP
- Japan
- Prior art keywords
- glycerol
- alpha
- chelating agent
- phosphate
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明はL−α−グリセロール−3−リン酸オキシタ゛
−ゼ(以下GPOと略称する。箇の安定化法に関するも
のであり、更に詳しくは、〕裏ビンアデニンジヌクレオ
チド(以下FADと略称する。)またはキレート剤を、
それぞれ単独に、もしく′は、両者を混合して加え為こ
とにより、GP□0を安定化する方法に関するものであ
る6″ □GPOは酵素法による中性脂肪の測定
に使用さ゛れる。゛すなわち、中性脂肪をリボプロティ
ンリパーゼ等により加水分解し、得られるグリセロール
に、ア・デノシン三1」ン酸(ATP)とMg2+イオ
ンどの存在下でグ、リセロールキナーゼを作用させて、
アデノシンニリン酸(ADP)とクリセロ−ルー3−リ
ン酸とを得る。このグリセロール−3゜−リン酸にGP
Oを作用さすて、発生する過酸化水素を、パーオキシダ
ーゼ−4−アミノアンチピリン錦色系に導き、虫取する
キノン色素を比色定量する仁とにより、中性脂肪を定量
する。これを反応経路)に俤って、示せば、次のとおり
である。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for stabilizing L-α-glycerol-3-phosphate oxidase (hereinafter abbreviated as GPO); (hereinafter abbreviated as FAD) or a chelating agent,
This relates to a method of stabilizing GP□0 by adding each one alone or as a mixture of the two. That is, neutral fats are hydrolyzed by riboprotein lipase or the like, and the resulting glycerol is treated with glycerol kinase in the presence of adenosine tertiary acid (ATP) and Mg2+ ions.
Adenosine diphosphoric acid (ADP) and chrysero-ru-3-phosphate are obtained. GP to this glycerol-3゜phosphate
The hydrogen peroxide generated by the action of O is introduced into the peroxidase-4-aminoantipyrine brocade system, and neutral fats are determined by colorimetric determination of the quinone pigment to be removed. The reaction route (reaction route) is shown as follows.
グリセロール+3脂肪酸
゛ グリセロールキナーゼ
グリセロール+ATP−Mg2+
グリセロール−6゛−リン酸+ADP−Mg”H2O2
+ジヒドロキシアセトンリン酸Hw (h + 4−7
□セノアンチビリン+フ工ノール等二!が底ヤ7.。Glycerol + 3 fatty acids゛ Glycerol kinase glycerol + ATP-Mg2+ Glycerol-6゛-phosphate + ADP-Mg”H2O2
+ dihydroxyacetone phosphate Hw (h + 4-7
□Senoantibilin + phenol, etc. 2! The bottom is 7. .
従来法では、たとえば、中性脂肪のアルカリケン化によ
り得たグリセロールを過ヨウ素酸酸化し、生成したホル
ムアルデヒドをクロモトロープ酸またはアセチルアセト
ンに□より呈色させて、比色定量する方法が用いられて
いたが、夾雑物の影響を避けるために溶媒抽出などの予
備処理を必要とし、゛操作が煩雑で、測定に長時間を要
するという欠点を痔っていた。In the conventional method, for example, glycerol obtained by alkaline saponification of neutral fats is oxidized with periodic acid, and the resulting formaldehyde is colored with chromotropic acid or acetylacetone, which is then used for colorimetric determination. However, this method requires preliminary treatment such as solvent extraction to avoid the influence of contaminants, and suffers from the drawbacks of complicated operations and long measurement times.
この欠点は、酵素反応を用いること咳より、一応の解決
を見た。すなわち、酵素による反応は基質特異性が高く
、通常の夾雑物は防害とならないので、試料の精製のよ
う左前処理を必要とせず、迅速な測定が可能である。□
しかし、その反面、使用する酵素が溶液中で極めて不安
定であるという大きが欠点を持っておシミ新しい課題の
解決が求められている。This drawback was temporarily solved by using an enzyme reaction. That is, the enzyme reaction has high substrate specificity, and ordinary contaminants do not act as a deterrent, so rapid measurement is possible without the need for pretreatment such as sample purification. □
However, on the other hand, it has a major drawback in that the enzymes used are extremely unstable in solution, and new solutions are needed.
GPOも、一般の酵素同様安定性に欠け、自動分析器に
利用した場合、試薬溶液を頻繁に交換する必要が生じて
、試薬の浪費が多く、自動分析器の機能を十分には発揮
できない。Like general enzymes, GPO lacks stability, and when used in an automatic analyzer, the reagent solution needs to be replaced frequently, leading to wasted reagents and the automatic analyzer's functions cannot be fully utilized.
本件発明者らは、か\る困難を克服するために鋭意検討
した結果、FADまたはキレート剤をそりずれ、単独に
、もしくは、両者を混合して添加すれば、GPO溶液の
安定性が著しく向上することを見出して、本発明を完成
するに至った。すなわち、本発明は、GPOを含有する
緩衝液に、FADまたは一門謬汰をそれぞれ単独に、ま
たは、両者を混合して添加することを特徴とする、GP
Oの安定化に関するものである。
。As a result of intensive studies to overcome such difficulties, the inventors of the present invention found that the stability of GPO solutions can be significantly improved by adding FAD or a chelating agent, either alone or as a mixture of the two. The present invention was completed based on this discovery. That is, the present invention is characterized in that FAD or Ichimon Yotata is added to a buffer containing GPO, either alone or as a mixture of the two.
This is related to the stabilization of O.
.
FADがG’POの補酵素であることは、文献(たとえ
ばり、 L、 Koditscheck 、 W 、
W 、 Umbreit。The fact that FAD is a coenzyme of G'PO has been confirmed in the literature (for example, Li, L., Koditcheck, W.
W., Umbreit.
J、ofBacteriology、98 1063(
1969))にも記載された公知の事実であるが、FA
Dを加えることにより、GPOの水溶液が、広い温度域
で長期間安定化することは、予想だにされなかった。さ
らに、キレート剤の添加がGPOの安定化に効果がある
ことは、全く予知されなかったことである。J, of Bacteriology, 98 1063 (
This is a well-known fact described in 1969)), but FA
It was unexpected that the addition of D would stabilize an aqueous solution of GPO over a wide temperature range for a long period of time. Furthermore, it was completely unexpected that the addition of a chelating agent would be effective in stabilizing GPO.
本発明の方法を自動分析装置に適用すれば、長期間にわ
たって、酵素を連続使用することが可能になり、能率お
よび費用の面で大きな改善が期待できる。If the method of the present invention is applied to an automatic analyzer, enzymes can be used continuously over a long period of time, and significant improvements can be expected in terms of efficiency and cost.
本発明は1.いかなる起源のGPOにも適用できる。ま
た、本発明に使用するFADも、いかなる起源のもので
あってもよい◎
本発明に使用するキレート剤け、いか彦る種類のもの″
であってもよいが、たとえば、エチレンジアミン四酢酸
(EDTA)、エチレングリコールエーテルジアミン四
酢酸(EGTA)等が挙げられる。The present invention consists of 1. Applicable to GPOs of any origin. Furthermore, the FAD used in the present invention may be of any origin.
Examples thereof include ethylenediaminetetraacetic acid (EDTA), ethylene glycol ether diaminetetraacetic acid (EGTA), and the like.
本発明に用いる緩衝液の好ましいpH′範゛囲゛は5、
Ov9.0である。・また、FADの濃度は9.01〜
50mM/11好ましくは0.05〜5 mM/l−。The preferred pH range of the buffer used in the present invention is 5,
Ov9.0.・Also, the concentration of FAD is 9.01~
50mM/11 preferably 0.05-5mM/l-.
キレート剤の濃度は0.1〜200 mM/を好ましく
110.5〜10 mM/lである。The concentration of the chelating agent is 0.1 to 200 mM/l, preferably 110.5 to 10 mM/l.
なシ、本発明で使用するGPOの酵素活性は、たとえば
、以下に述べる方法で測定することができる。However, the enzymatic activity of GPO used in the present invention can be measured, for example, by the method described below.
バーオキシダ1−ゼ0.,58 u / d 、 4.
−ア、ミノアンチピリン0.25 mM 、 フェノー
ル25mMおよび酢酸マグネシウム1.5mMを含tr
pH7,5ノ0.1M/l)リス塩酸緩衝液0.5dK
検体3CVptを添加混合し、37℃で1〜2分間予備
加温(プレインキューベー、′ヨン)スル。ついで、8
0mM/lグリセロールー3−リン酸溶液100ptを
添加し、37℃で1〜3分間反応させる。生成するキノ
ン色素による500tmの吸光度の増加速度を測定ずぶ
ととKjって、酵素活性を求める。Veroxidase 1-ase 0. , 58 u/d, 4.
-A, containing 0.25 mM minoantipyrine, 25 mM phenol and 1.5 mM magnesium acetate.
pH7.5 0.1M/l) Liss-HCl buffer 0.5dK
Add sample 3CVpt, mix and preheat at 37°C for 1 to 2 minutes. Then, 8
Add 100 pt of 0mM/l glycerol-3-phosphate solution and react at 37°C for 1 to 3 minutes. The enzyme activity is determined by measuring the rate of increase in absorbance at 500 tm due to the quinone dye produced.
次に1本発明番−施例忙より具体的に説明する。Next, the present invention will be explained in more detail by way of example.
実施例1
0.1M/lヘベス緩衝液(1)H5,0〜9.0 )
に、ア亡ロコッカス・ビリデ77 (Aerococc
us Viri −dans ) 由来のG P Q
’k 2〜3 u /−の濃度になるように加え、こ
れにFAD (最終濃度0.1 mM/1)を単独に、
また畔、EDTA (最終濃度21
mM/l)と混合して添加し、試験溶液を調製する。そ
の溶液を27℃、!7日間保存し、残存活性を測定した
。結果を第1.表に示す。Example 1 0.1M/l Heves buffer (1) H5.0-9.0)
Aerococcus viride 77 (Aerococc)
G P Q derived from us Viri-dans)
' k 2-3 u/-, and FAD (final concentration 0.1 mM/1) was added alone.
In addition, a test solution is prepared by mixing and adding EDTA (final concentration 21 mM/l). The solution was heated to 27℃! It was stored for 7 days and the residual activity was measured. Results first. Shown in the table.
実施例、2 、 。Example, 2.
0.1M/lヘペス緩衝液(pH5,0〜9.0 )に
、アエロコツカスeビリダyス(Aerococcus
Viri−dans )由来のGPOを2〜3u/−
の濃度になるように加え、これに、FAD(最終濃度0
.1 mM/l)およびEDTA (最終濃32 m
M / L )をそれぞれ単独に、または、両者を混合
して添加し、試験溶液を調製する。その溶液を27℃で
6日間保存し、残存活性を測定した。結果を第2表に示
す。Aerococcus e viridides was added to 0.1 M/l Hepes buffer (pH 5.0-9.0).
Viri-dans) derived GPO from 2-3u/-
To this, FAD (final concentration 0
.. 1 mM/l) and EDTA (final concentration 32 m
M/L) are added individually or as a mixture of both to prepare a test solution. The solution was stored at 27°C for 6 days and the residual activity was measured. The results are shown in Table 2.
(以下余白)
第1表
*試験液組成lは0.1M/lヘペス緩衝液のみ■はF
ADを単独に加えたもの
■はFADおよびEDTAを加えたものpH5,0およ
びpH9,0では、ヘペスの緩衝作用が弱いのでpH値
はや\不安定である。(Leaving space below) Table 1 *Test solution composition l is 0.1M/l Hepes buffer only ■ is F
When AD is added alone, FAD and EDTA are added. At pH 5.0 and pH 9.0, the pH value is somewhat unstable because the buffering effect of Hepes is weak.
第2表
*試験液組成1jo、IM/lヘベス緩衝液のみ■はF
ADを単独に加えたもの
■はEDTAを単独に加えたもの
mV ll1FADおよびEDTAを加えたものpH5
,0およびpH9,0ではヘペスの緩衝作用が弱いので
pH値はや\不安定である。Table 2 *Test solution composition 1jo, IM/l Heves buffer only ■ is F
AD added alone (■) EDTA added alone mV ll1 FAD and EDTA added pH 5
, 0 and pH 9, 0, the buffering effect of Hepes is weak, so the pH value is somewhat unstable.
Claims (1)
有する緩衝液にフラビンアデニンジヌクレオチドまたは
キレート剤をそれぞれ単独(、もしくは、両者を、混合
して加えることを特徴とする、L−α−クリセロ−ルー
3−リン酸オキシター、ゼ、の安定化法。L-α-L-α-IJ cello-3-phosphate oxidase-containing buffer solution containing flavin adenine dinucleotide or a chelating agent, respectively (or a mixture of both) - A method for stabilizing chrysero-ru-3-phosphate oxidase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12364782A JPS5914788A (en) | 1982-07-15 | 1982-07-15 | Stabilization of l-alpha-glycerol-3-phosphate oxidase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12364782A JPS5914788A (en) | 1982-07-15 | 1982-07-15 | Stabilization of l-alpha-glycerol-3-phosphate oxidase |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5914788A true JPS5914788A (en) | 1984-01-25 |
Family
ID=14865768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12364782A Pending JPS5914788A (en) | 1982-07-15 | 1982-07-15 | Stabilization of l-alpha-glycerol-3-phosphate oxidase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5914788A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60126084A (en) * | 1983-12-13 | 1985-07-05 | Toyo Jozo Co Ltd | Stabilized glycerohosphate oxidase composition |
US5156966A (en) * | 1989-10-13 | 1992-10-20 | Toyo Jozo Kabushiki Kaisha | L-carnitine dehydrogenase and process for its production |
US5192657A (en) * | 1990-12-18 | 1993-03-09 | Ortho Diagnostic Systems, Inc. | Stabilized proteolytic solution and reagent kit |
JP2010022328A (en) * | 2008-07-23 | 2010-02-04 | Aisin Seiki Co Ltd | Method for stabilizing coenzyme-binding enzyme, and composition, enzyme sensor and fuel cell prepared by using the stabilization method |
-
1982
- 1982-07-15 JP JP12364782A patent/JPS5914788A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60126084A (en) * | 1983-12-13 | 1985-07-05 | Toyo Jozo Co Ltd | Stabilized glycerohosphate oxidase composition |
JPH0446558B2 (en) * | 1983-12-13 | 1992-07-30 | Toyo Jozo Kk | |
US5156966A (en) * | 1989-10-13 | 1992-10-20 | Toyo Jozo Kabushiki Kaisha | L-carnitine dehydrogenase and process for its production |
US5173416A (en) * | 1989-10-13 | 1992-12-22 | Toyo Jozo Kabushiki Kaisha | L-carnitine dehydrogenase from alcalgenes |
US5192657A (en) * | 1990-12-18 | 1993-03-09 | Ortho Diagnostic Systems, Inc. | Stabilized proteolytic solution and reagent kit |
JP2010022328A (en) * | 2008-07-23 | 2010-02-04 | Aisin Seiki Co Ltd | Method for stabilizing coenzyme-binding enzyme, and composition, enzyme sensor and fuel cell prepared by using the stabilization method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carroll et al. | A colorimetric serum glucose determination using hexokinase and glucose-6-phosphate dehydrogenase | |
Shimizu et al. | Enzymatic microdetermination of serum free fatty acids | |
US4368261A (en) | Method and reagent for the determination of triglycerides | |
Akimoto et al. | Luminol chemiluminescence reaction catalyzed by a microbial peroxidase | |
EP0024578B1 (en) | Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor | |
TAKEMORI | STUDIES ON CYTOCHROME A V. PROPERTIES OF COPPER IN PURIFIED CYTOCHROME A | |
NAGATSU et al. | A simple assay of monoamine oxidase and D-amino acid oxidase by measuring ammonia | |
CA1144051A (en) | Method for the analysis of triglycerides | |
JPS5914788A (en) | Stabilization of l-alpha-glycerol-3-phosphate oxidase | |
JPH04229192A (en) | Stable aqueous nadh reagent and kit | |
JP4639287B2 (en) | Stabilization method for enzymatic measurement reagents | |
US4409326A (en) | Stabilized enzymatic solutions and method for determining total cholesterol in human serum | |
EP0285998B1 (en) | Method and reagent for determination of dehydrogenase or its substrate | |
EP0100217A2 (en) | Process for quantitative determination of substrate treated with oxidase | |
US5250420A (en) | Method and reagent for determination of dehydrogenase or its substrate | |
EP0044432A2 (en) | Stabilized enzymatic solutions and method for determining total cholesterol in human serum | |
US5474908A (en) | Method of enzymatically measuring hydrogen peroxide and reagent therefor | |
Behm et al. | Studies of regulatory metabolism in Moniezia expansa: the role of phosphofructokinase (with a note on pyruvate kinase) | |
JP2534859B2 (en) | Enzyme assay for biological materials | |
JPH0815430B2 (en) | Method for stabilizing ascorbate oxidase | |
JP2663257B2 (en) | Method for stabilizing reagent for measuring biological components | |
Maguire | Elimination of the" chromogen oxidase" activity of bilirubin oxidase added to obviate bilirubin interference in hydrogen peroxide/peroxidase detecting systems. | |
JPH0671437B2 (en) | Reagent for quantifying magnesium ion | |
JPH05103697A (en) | Composition for eliminating ammonium ion | |
US5840512A (en) | Method for measurement of ionized calcium |